Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Venous Thromboembolism 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Hemorrhage 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Breast Neoplasms 1

Interventions

Oxaliplatin 42 Fluorouracil 27 Capecitabine 24 pembrolizumab 21 S 1 (combination) 19 Paclitaxel 19 Leucovorin 16 Nivolumab 13 Docetaxel 13 sintilimab 12 Drug Therapy 12 Trastuzumab 11 tislelizumab 10 Cisplatin 10 Irinotecan 9 Bevacizumab 8 trastuzumab deruxtecan 7 spartalizumab 7 XELOX 7 Surgical Procedures, Operative 7 Radiotherapy 7 Hyperthermic Intraperitoneal Chemotherapy 7 Biopsy 7 fludarabine 6 disitamab vedotin 6 Cyclophosphamide 6 lenvatinib 5 apatinib 5 Specimen Handling 5 Ramucirumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × Aspirin × Clear all

NCT04214990 2024-12-27

EASTERN

National Cancer Center, Korea

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡